Senior Statistician II at AstraZeneca
Joined January 2019
- Tweets70
- Following186
- Followers118
- Likes134
Pinned Tweet
I’ve written a paper developing methods to adjust for verification bias in diagnostic accuracy measures when comparing multiple screening tests, and then applied these methods to IP1-PROSTAGRAM trial data rdcu.be/cJuDO 📖 just published and incredibly proud!!! 🥳
We published a paper exploring the results of cardiac surgery during the COVID-19 pandemic compared with previous years: a propensity weighted study of outcomes at six months - Give it a read! 📖 #propensityweighting #covid19 @Francy_lif journals.sagepub.com/eprint/…
Congratulations Dr @RachPips!! 🥳🥳
Congratulations to @RachPips who passed her PhD viva today, we are so very proud of you! #PhD #Congratulations 🎉🎉🎉✨✨✨👩🎓👩🎓👩🎓
1
Emily Day retweeted
New statistical analysis plan publication for feasibility phase of the CHRONOS study including 2 parallel randomised trials & the first MAMS surgical trial in #prostatecancer by @EmilyD_stats @Francy_lif et al #Trials trialsjournal.biomedcentral.…
I’ve had such an amazing time working at ICTU over the past 2 and a half years! I’ll miss you all 🤗
2
Emily Day retweeted
Join us June 8th to hear from @Deborah_Ashby & @RachPips discussing 'Improving treatments for patients: Why statisticians count' at the next @imperialcollege Current and Future Women Luminaries event, hosted by President @Alicegast
Registration: bit.ly/3ikFZE6
Emily Day retweeted
Inspired by a recent twitter post from @ADAlthousePhD
Nick Johnson finds himself mulling over adjustments for multiple testing. A blog by @nickjohnsonictu
statsci.co.uk/post/mulling-o…
Emily Day retweeted
IP4-CHRONOS (A).
Our last attempt to show whether randomised data can be collected for focal HIFU and cryotherapy compared to radical therapy.
Let’s see if all those calling for randomised data will support to recruit over next 6 months...
Congratulations to Imperial College Healthcare NHS Trust in opening IP4 CHRONOS- investigating treatments for men with localised, clinically significant prostate cancer: imperialprostate.org.uk/chro…
@ProstateUK @LondonProstate1 @ImperialSandC @Reddy4Urology @TaimurShah @IP_London
Emily Day retweeted
A handy infographic of our recently published research
Full paper is open access and free for all 🔬📜🙌
👉jamanetwork.com/journals/jam…
@eldredevans @JAMAOnc @EmilyD_stats @SageOfLondon1 @Connor_Urol @ImperialSandC @LondonProstate1 @Francy_lif @ProfPadhani @HemmySokhi
Emily Day retweeted
Emerging evidence suggests that MRI could be a new screening test for #prostatecancer ja.ma/3d3NxbG @eldredevans @LondonProstate1 @EmilyD_stats @ProfPadhani @HemmySokhi #PROSTAGRAM
Emily Day retweeted
Congratulations to the IP1-PROSTAGRAM Team for making it onto the front page of the Daily Telegraph 🙌🔬
Also widespread coverage in others newspaper
✅theguardian.com/society/2021…
✅dailymail.co.uk/sciencetech/…
✅thesun.co.uk/news/14020860/n…
@EmilyD_stats @BurakPaula @eldredevans
Emily Day retweeted
Surreal to see our research on front page of @dailytelegraph. Thanks @PhoebeS1992
➡️ Read at telegraph.co.uk/news/2021/02…
@LondonProstate1 @HemmySokhi @SageOfLondon1 @ProfPadhani @EmilyD_stats
Emily Day retweeted
New prostate cancer scan 'could replace invasive exam and save lives' theguardian.com/society/2021…
Emily Day retweeted
IP1-PROSTAGRAM just published in @JAMAOnc📢
“Short, non-contrast MRI may have favourable performance characteristics as a screening test”
➡️jamanetwork.com/journals/jam…
@eldredevans @LondonProstate1 @HemmySokhi @ProfPadhani @Francy_lif @imperialurology @ImperialSandC @TUF_tweets
The IP-1 PROSTAGRAM Study: ja.ma/3pebdg1 via @JAMAOnc part of @JAMANetwork - comparing the performance of PSA testing, MRI, and ultrasonography as screening tests for prostate cancer in a prospective, population-based cohort study 👏🏼👏🏼
Well done and great work @LondonProstate1 @eldredevans @Francy_lif @BurakPaula @HemmySokhi @ProfPadhani and many others 👏🏼
1